Evidence map›Paper›PMID 26892626›Full record

ArticleMolecular neurobiology2017

Clearance of Damaged Mitochondria Through PINK1 Stabilization by JNK and ERK MAPK Signaling in Chlorpyrifos-Treated Neuroblastoma Cells.

Jae Hyeon Park, Juyeon Ko, Yun Sun Park, Jungyun Park, Jungwook Hwang, Hyun Chul Koh

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review).International journal of molecular medicine · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Autophagy and Metabolism in Normal and Malignant Hematopoiesis.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Review
  15. Oxidative Stress and Analysis of Selected SNPs ofInternational journal of molecular sciences · 2020
    Article
  16. Organophosphorus Compounds and MAPK Signaling Pathways.International journal of molecular sciences · 2020
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jae Hyeon ParkHanyang Biomedical Research Institute, Hanyang University, 133-791, Seoul, Republic of Korea.
Juyeon KoHanyang Biomedical Research Institute, Hanyang University, 133-791, Seoul, Republic of Korea.
Yun Sun ParkHanyang Biomedical Research Institute, Hanyang University, 133-791, Seoul, Republic of Korea.
Jungyun ParkHanyang Biomedical Research Institute, Hanyang University, 133-791, Seoul, Republic of Korea.
Jungwook HwangHanyang Biomedical Research Institute, Hanyang University, 133-791, Seoul, Republic of Korea. jwhwang@hanyang.ac.kr.
Hyun Chul KohHanyang Biomedical Research Institute, Hanyang University, 133-791, Seoul, Republic of Korea. hckoh@hanyang.ac.kr.
Hanyang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial quality control and clearance of damaged mitochondria through mitophagy are important cellular activities. Studies have shown that PTEN-induced putative protein kinase 1 (PINK1) and Parkin play central roles in triggering mitophagy; however, little is known regarding the mechanism by which PINK1 modulates mitophagy in response to reactive oxygen species (ROS)-induced stress. In this study, chlorpyrifos (CPF)-induced ROS caused mitochondrial damage and subsequent engulfing of mitochondria in double-membrane autophagic vesicles, indicating that clearance of damaged mitochondria is due to mitophagy. CPF treatment resulted in PINK1 stabilization on the outer mitochondrial membrane and subsequently increased Parkin recruitment from the cytosol to the abnormal mitochondria. We found that PINK1 physically interacts with Parkin in the mitochondria of CPF-treated cells. Furthermore, a knockdown of PINK1 strongly inhibited the LC3-II protein level by blocking Parkin recruitment. This indicates that CPF-induced mitophagy is due to PINK1 stabilization in mitochondria. We observed that PINK1 stabilization was selectively regulated by ROS-mediated c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling activation but not p38 signaling. In the mitochondria of CPF-exposed cells, pretreatment with specific inhibitors of JNK and ERK1/2 significantly decreased PINK1 stabilization and Parkin recruitment and blocked the LC3-II protein level. Specifically, JNK and ERK1/2 inhibition also dramatically blocked the interaction between PINK1 and Parkin. Our results demonstrated that PINK1 regulation plays a critical role in CPF-induced mitophagy. The simple interpretation of these results is that JNK and ERK1/2 signaling regulates PINK1/Parkin-dependent mitophagy in the mitochondria of CPF-treated cells. Overall, this study proposes a novel molecular regulatory mechanism of PINK1 stabilization under CPF exposure.

Indexed as

Cell Line, TumorChlorpyrifosCholinesterase InhibitorsDose-Response Relationship, DrugExtracellular Signal-Regulated MAP KinasesHumansJNK Mitogen-Activated Protein KinasesMitochondriaNeuroblastomaProtein KinasesProtein StabilityPTEN-Induced Putative KinaseReactive Oxygen SpeciesChlorpyrifosCholinesterase InhibitorsExtracellular Signal-Regulated MAP KinasesJNK Mitogen-Activated Protein KinasesProtein KinasesPTEN-Induced Putative KinaseReactive Oxygen SpeciesERK1/2 MAPKJNKMitophagyParkinPINK1 stabilization

Identifiers

PMID26892626
OpenAlexW2280814712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.